StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
(NASDAQ: NVCT) Delayed: 22.00 +0.62 (2.90%)
Previous Close $21.38    52 Week High $ 
Open $21.27    52 Week Low $ 
Day High $23.00    P/E N/A 
Day Low $21.06    EPS $ 
Volume 880,119